文献速递哮喘

维生素D在哮喘中的作用机制与临床试验考量

Vitamin D in Asthma: Mechanisms of Action and Considerations for Clinical Trials.
PubMed 文献 · Chest · 2017-09-18

本文综述维生素D在哮喘中的作用机制及临床试验设计问题。维生素D通过调节淋巴细胞、肥大细胞、抗原提呈细胞和结构细胞等多条免疫通路,抑制过度炎症反应,并增强激素反应性和抗菌防御。尽管随机对照试验结果不一致,但系统综述显示维生素D对哮喘有益,支持将其纳入哮喘整体管理。

要点

  • 维生素D可调节多条免疫通路,抑制哮喘过度炎症反应
  • 维生素D增强重症哮喘患者对激素的反应性并改善抗菌防御
  • 系统综述显示维生素D对哮喘有益,支持优化维生素D在整体哮喘管理中的作用

核心结论

  • 维生素D通过多机制在哮喘中发挥有益作用,系统综述显示其对哮喘有益,支持优化维生素D在整体哮喘管理中的重要性。

研究设计与样本

  • 本文为综述,汇总维生素D在哮喘中作用机制及临床试验相关证据。

主要发现

  • 维生素D调节淋巴细胞、肥大细胞、抗原提呈细胞和结构细胞以抑制过度炎症反应。
  • 维生素D支持免疫调节,与过敏性哮喘免疫耐受失败相关。
  • 维生素D调节与非过敏性嗜酸性炎症相关的警报素细胞因子。
  • 维生素D增强重症哮喘患者对激素的反应并改善病理性IL-17反应。
  • 维生素D增强抗菌通路,与感染诱发的哮喘急性加重相关。

临床怎么用

  • 将优化维生素D纳入哮喘整体管理。
  • 关注维生素D作为二级预防以减少哮喘急性加重和炎症的潜在作用。
  • 孕期维生素D可能对减少儿童哮喘发生具有一级预防作用。

局限性

  • 随机对照试验设计不一,阳性结果不一致。
  • 需进一步理解维生素D生物学特征以解释某些阴性结果的方法学问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is increasing interest in the therapeutic utility of vitamin D in asthma, which is supported by a significant body of evidence on epidemiologic associations between vitamin D insufficiency and worse asthma control. In support of a causal relationship, vitamin D beneficially modulates diverse immunologic pathways in heterogeneous asthma endotypes, regulating the actions of lymphocytes, mast cells, antigen-presenting cells, and structural cells to dampen excessive inflammatory responses. Allergic asthma is characterized by a failure of immune tolerance and the development of pathologic responses to inhaled aeroallergens, and vitamin D has been extensively shown to support immune regulation. Alarmin cytokines are increasingly implicated in nonallergic eosinophilic inflammation, which vitamin D also regulates. Steroid resistance and pathologic interleukin (IL)-17 responses are features of severe asthma, and vitamin D beneficially enhances the response to steroids in these individuals. Additionally, vitamin D enhances antimicrobial pathways, which is of relevance to infection-precipitated asthma exacerbations. These mechanisms support a role for vitamin D as secondary prevention to reduce exacerbations and inflammation in asthma. Similar mechanisms, and effects on fetal lung development, likely underlie a primary prevention therapeutic role in pregnancy for vitamin D to reduce the development of asthma in children. However, randomized controlled trials of variable design show inconsistent positive outcomes for vitamin D interventions in asthma. Increased understanding of the biological characteristics of vitamin D reveals methodological issues that might explain certain negative outcomes. Importantly, on systematic review of the trials to date, vitamin D is shown to be beneficial in asthma. The evidence discussed in this review supports the importance of optimizing vitamin D in holistic asthma care.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Pfeffer PE, Hawrylowicz CM. Vitamin D in Asthma: Mechanisms of Action and Considerations for Clinical Trials. Chest. 2017. PMID: 28923762. doi:10.1016/j.chest.2017.09.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。